This page is intended for B2B pharma channels only and contains information on available Sandoz B2B products and services, not all of which are available in every location.
50 years of serving third-party customers
Sandoz B2B is a global business unit providing third-party pharmaceutical companies with access to an extensive portfolio of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). These are manufactured to the highest standards across our global network.
We are also a leading contract development and manufacturing organization (CDMO), providing end-to-end solutions for our partners’ needs. We offer a full range of services from pharmaceutical bulk production to final packaging. Our well-established global network of sites, that are regularly audited by the most stringent Health Authorities, guarantees quality at each step of the manufacturing process.
3 business offerings. 1 reliable partner.
Active pharmaceutical ingredients (APIs)
Thanks to our fully-backward-integrated penicillin facility in Kundl, Austria, we provide pharmaceutical companies with sustainable, independent access to a portfolio of antibiotic APIs and intermediates focused on Pot Clav.
Finished dosage forms (FDFs)
Our partners also get access to an extensive portfolio of finished dosage products including more than 520 products across 12 therapeutic areas.
Contract development & manufacturing (CDMO)
We provide our partners with access to a global network of development centers and manufacturing facilities, with broad capabilities covering all major technologies.
Dedicated teams. Agile set-up.
Sandoz B2B is specialized in serving its customers with independent set-up and exclusive project teams, ensuring the highest level of confidentiality. This way of operating is key to protecting the intellectual property of our partners – and guarantees a lean, efficient process.
The global leader in generic antibiotics
For more than 75 years, we have been supplying high-quality antibiotics from our facility in Kundl, Austria, the last remaining fully backward integrated production facility for penicillin antibiotics in Europe.
The Sandoz portfolio covers over 50% of the antibiotics available giving us the opportunity to serve a broad majority of today’s antibiotic needs.
FDF portfolio covering 520+ products across 12 therapeutic areas
Access to a global network of CDMO facilities.
CDMO services across all major technologies.
Injectables & Liquids
- Liquid filling in vials & ampoules
- Lyophilization in vials
- Nasal sprays & oral liquids
- Manufacturing of products up to category 3 (excl. hormones & cytotoxic)
- Formulation and process development
Solids & Semi-solids
- Bulk & FDF manufacturing
- Solid and semi-solid products
- Blistering, bottle packaging, osmotic-controlled release oral delivery system (OROS), MUT, creams and gels
- Commercial scale
- Dedicated facilities for anti-infectives, ß-lactams and non Anti-Infectives
- Formulation and process development
Respiratory
- Pressurized Metered Dose Inhaler
- (MDI) manufacturing
- Dry Powder Inhaler (DPI) manufacturing
- Pilot and commercial scale
- Formulation and process development
Transdermal products
- Transdermal patch manufacturing
- Pilot and commercial scale
- Formulation and process development
Our locations
Sandoz B2B Global HQ
Biochemiestrasse 10 A-6250 Kundl, Tyrol Austria
Americas Regional Office
100 College Road West Princeton, NJ 08540 USA
APMA Regional Office
20 Pasir Panjang Road#10-25/28 Mapletree Business City 117439 Singapore